microRNA 4538 (MIR4538)

microRNA 4538 (MIR4538) is a small non-coding RNA molecule belonging to the microRNA family, which are key post-transcriptional regulators of gene expression in animals and plants[3][5]. MicroRNAs bind to complementary sequences on target messenger RNAs (mRNAs), typically resulting in translational repression or target degradation and gene silencing[2][3][5]. microRNA 4538 itself is not reported as a therapeutic target, receptor, enzyme, transporter, or similar druggable molecule and no evidence was identified of interacting drugs, targeted therapies, or specific disease mutations directly involving MIR4538. Its main role, aligned with all microRNAs, is to fine-tune gene expression in processes such as cell proliferation, differentiation, apoptosis, and potentially tumorigenesis[2][4]. microRNA expression patterns, including those of MIR4538, can serve as diagnostic or prognostic biomarkers in disease states, especially in cancer[1]. No unique disease association, drug interaction, or therapeutic application specific to MIR4538 was identified in available sources. Essential context and supporting details: - “microRNA” refers to a class of small endogenous non-coding RNAs (~22 nucleotides) that regulate gene expression at the post-transcriptional level by binding to the 3’UTR or other regions of mRNAs[2][3][5]. - microRNAs can regulate hundreds of target genes, affecting pathways central to cell cycle, apoptosis, and differentiation[4][5]. - While microRNAs as a class are increasingly viewed as biomarkers and potential targets or tools in therapy (especially cancer), individual microRNAs require specific functional and clinical data before they are considered therapeutic targets[1][2]. - No evidence supports MIR4538 as a drug target, and no known drugs directly interact with it. Inference and limitations: - There is no literature indicating MIR4538 is recognized as a bona fide therapeutic target, nor is it described as having targetable receptor/enzyme/transporter function. - The information for MIR4538 itself (as opposed to the microRNA family generally) is very limited. Thus, “is_incorrect” is set to true, as MIR4538 does not appear to be a well-characterized or “druggable” target in the sense intended by most pharmaceutical or biological databases.

Other names

hsa-mir-4538MIR4538hsa-miR-4538